Supplement Industry Battle Against States Imposing Age-Restricted Sales Swings To NJ

Council for Responsible Nutrition contends New Jersey bill, which Assembly Health Committee amended with substantial language to make restrictions more stringent on 23 September, is targeted as inaccurately as restrictions in New York effective in April.

• Source: Shutterstock

The number of states age-restricting sales of dietary supplements and OTC drugs for weight loss and bodybuilding could increase to two before the end of 2024 as New Jersey legislatures start movement on a bill been dormant since January.

More from Legislation

Kenvue Applauds UK Government Move To Create ‘First Smokefree Generation’

 
• By 

Kenvue backs UK government legislation proposing to remove access to nicotine products, including vapes, to under 18s and ban their advertising and sponsorship.

APAC Congress: Regulators And Industry Agree ‘Bangkok Joint Initiative on Self-Care’

 
• By 

Organizations representing APAC health and medicines regulators and the consumer health industry respectively have agreed to “recognize the importance of self-care as a fundamental pillar of health and wellbeing” and “affirm our dedication to advancing self-care as an essential component of Universal Health Coverage.”

Reverse-Switching OTC Antimicrobials Could Cost Europe An Additional €10bn Per Year

 
• By 

Over five years, the cost of the European Commission's proposal could exceed a total €50bn, finds a study by IQVIA commissioned by the AESGP.

Industry Support Key To US FDA’s Prospects Under Trump – Califf

 
• By 

The FDA's current leader, whose term will end with Donald Trump’s second inauguration, also described three qualities the agency’s next commissioner will need to succeed, including "believing that there is such a thing as expertise."

More from Policy & Regulation

US FDA Principal Deputy Commissioner Bumpus Leaving At Year’s End, Creating Leadership Void

 
• By 

Namandje Bumpus' departure means there is no obvious, internal candidate to serve as acting commissioner when President-elect Donald Trump takes office in January and the Senate works to confirm a new leader.

OTC ACNU Final Rule Publication In December Included In US FDA’s Latest Regulatory Goals List

 

Latest regulatory goals update also includes April as target date for final rule on exemptions from IND clearance for clinical trials to evaluate food, dietary supplements or cosmetics and May for an NPRM would recognize N-acetyl-L-cysteine as a lawful dietary ingredient.

France Reverse-Switches Pseudoephedrine OTCs Over Long-Running Safety Concerns

 
• By 

Oral pseudoephedrine decongestants marketed by Kenuve, Haleon and Opella, amongst others, are now only available with a doctor's prescription in France.